Alzheimer's drug tested as new hope for tough prostate cancer
NCT ID NCT07164794
Summary
This study is testing if a drug called memantine hydrochloride, commonly used for Alzheimer's disease, can help control advanced prostate cancer that has spread and stopped responding to standard hormone therapies. It will involve about 15 men who have already tried one or two other treatments. Researchers will see if adding memantine to their current care helps slow the cancer's growth and lowers their PSA levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.